Foundation Medical Partners

Nashua, New Hampshire 03060

0 studies enrolling now · 10 studies all time

What they study most

Advanced, Metastatic Breast Cancer, Breast Adenocarcinoma, Breast Cancer, Breast Ductal Carcinoma In Situ, Cardiac Toxicity, DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, Hormone Receptor Positive, Invasive Breast Carcinoma, Male Breast Carcinoma, Metastatic Malignant Neoplasm to the Bone, Multicentric Breast Carcinoma

Studies at this site

• Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer — Running, not enrolling
• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) — Running, not enrolling
• Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery — Completed
• Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer — Running, not enrolling
• Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery — Completed
• Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer — Completed
• Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance — Completed
• Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab — Completed
• Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement — Completed
• Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer — Completed